Article

• Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisResults of a phase III multicenter, double‐blind, placebo‐controlled trial

  K. P. Johnson, B. R. Brooks, J. A. Cohen, C. C. Ford, J. Goldstein, R. P. Lisak, L. W. Myers, H. S. Panitch, J. W. Rose, R. B. Schiffer, T. Vollmer, L. P. Weiner, J. S. Wolinsky, Copolymer 1 Multiple Sclerosis Study Group

  • Abstract
  • Full Text (PDF)
• Interferon beta‐lb in the treatment of multiple sclerosisFinal outcome of the randomized controlled trial

  The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group

  • Abstract
  • Full Text (PDF)
• Large hemispheric infarction, deterioration, and intracranial pressure

  Jeffrey I. Frank

  • Abstract
  • Full Text (PDF)
• Psychogenic basilar migraineReport of four cases

  F. Sanchez-Villasenor, O. Devinsky, B. Hainline, H. Weinreb, D. Luciano, B. Vazquez

  • Abstract
  • Full Text (PDF)
• Trigeminal neuralgia in multiple sclerosis

  John P. Hooge, W. K. Redekop

  • Abstract
  • Full Text (PDF)
• Persistent direction‐changing positional nystagmusAnother variant of benign positional nystagmus?

  Robert W. Baloh, Qing Yue, Kathleen M. Jacobson, Vicente Honrubia

  • Abstract
  • Full Text (PDF)
• Inclusion body myositisExplanation for poor response to immunosuppressive therapy

  R. J. Barohn, A. A. Amato, Z. Sahenk, J. T. Kissel, J. R. Mendell

  • Abstract
  • Full Text (PDF)
• Psychosis in advanced Parkinson's diseaseTreatment with ondansetron, a 5‐HT3 receptor antagonist

  Joseph Zoldan, Gali Friedberg, Myron Livneh, Eldad Melamed

  • Abstract
  • Full Text (PDF)
• Spinal dural arteriovenous fistulaThe pathology of venous hypertensive myelopathy

  R. W. Hurst, L. C. Kenyon, E. Lavi, E. C. Raps, P. Marcotte

  • Abstract
  • Full Text (PDF)
• Presymptomatic DNA and MRI diagnosis of neurofibromatosis 2 with mild clinical course in an extended pedigree

  M. Sainio, T. Strachan, G. Blomstedt, O. Salonen, K. Setälä, A. Palotie, J. Palo, I. Pyykkö, L. Peltonen, J. Jääskeläinen

  • Abstract
  • Full Text (PDF)
• Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease

  E. H. Corder, A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, J. B. Rimmler, P. A. Locke, P. M. Conneally, K. E. Schmader, R. E. Tanzi, J. F. Gusella, G. W. Small, A. D. Roses, M. A. Pericak-Vance, J. L. Haines

  • Abstract
  • Full Text (PDF)
• Wada memory asymmetries predict verbal memory decline after anterior temporal lobectomy

  D. W. Loring, K. J. Meador, G. P. Lee, D. W. King, M. E. Nichols, Y. D. Park, A. M. Murro, B. B. Gallagher, J. R. Smith

  • Abstract
  • Full Text (PDF)
• No association of the 11778 rnitochondrial DNA mutation and multiple sclerosis in Japan

  M. Nishimura, H. Obayashi, M. Ohta, T. Uchiyama, Q. Hao, T. Saida

  • Abstract
  • Full Text (PDF)
• Early reperfusion in the ‘spectacular shrinking deficit’ demonstrated by single‐photon emission computed tomography

  A. E. Baird, G. A. Donnan, M. C. Austin, W. J. McKay

  • Abstract
  • Full Text (PDF)
• Guamanian neurodegenerative diseaseInvestigation of the calcium metabolism/heavy meta1 hypothesis

  J. E. Ahlskog, S. C. Waring, L. T. Kurland, R. C. Petersen, T. P. Moyer, W. S. Harmsen, D. M. Maraganore, P. C. O'Brien, C. Esteban-Santillan, V. Bush

  • Abstract
  • Full Text (PDF)
• A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET

  S. Gilman, R. T. St. Laurent, R. A. Koeppe, L. Junck, K. J. Kluin, M. Lohman

  • Abstract
  • Full Text (PDF)
• Bilaterally symmetric hippocampi and surgical outcome

  C. R. Jack, M. R. Trenerry, G. D. Cascino, F. W. Sharbrough, E. L. So, P. C. O'Brien

  • Abstract
  • Full Text (PDF)
• Preoperative MRI predicts outcome of temporal lobectomyAn actuarial analysis

  S. F. Berkovic, A. M. McIntosh, R. M. Kalnins, G. D. Jackson, G.C.A. Fabinyi, G. A. Brazenor, P. F. Bladin, J. L. Hopper

  • Abstract
  • Full Text (PDF)
• Defective brain and muscle energy metabolism shown by in vivo ³¹P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation

  B. Barbiroli, P. Montagna, P. Cortelli, S. Iotti, R. Lodi, P. Barboni, L. Monari, E. Lugaresi, C. Frassineti, P. Zaniol

  • Abstract
  • Full Text (PDF)
• Isolation and characterization of autoreactive moteolioid protein‐peptide specific T‐cell clones from multiple sclerosis patients

  J. Correale, M. McMillan, K. McCarthy, T. Le, L. P. Weiner

  • Abstract
  • Full Text (PDF)
• Apraxia during Wada testing

  A. L. Foundas, R. Henchey, R. L. Gilmore, E. B. Fennell, K. M. Heilman

  • Abstract
  • Full Text (PDF)
• Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging

  G. Tedeschi, A. Bertolino, A. Righini, G. Campbell, R. Raman, J. H. Duyn, C.T.W. Moonen, J. R. Alger, G. Di Chiro

  • Abstract
  • Full Text (PDF)
• Seizure‐like discharges recorded in human dysplastic neocortex maintained in vitro

  Donatella Mattia, André Olivier, Massimo Avoli

  • Abstract
  • Full Text (PDF)
• Demonstration of thalarnic activation during typical absence seizures using H₂ ¹⁵O and PET

  M. C. Prevett, J. S. Duncan, T. Jones, D. R. Fish, D. J. Brooks

  • Abstract
  • Full Text (PDF)